NCT06989008 Enhancing Diabetes Care: Exposome &Amp; Sensors
| NCT ID | NCT06989008 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Illinois at Chicago |
| Condition | Type 2 Diabetes |
| Study Type | OBSERVATIONAL |
| Enrollment | 20 participants |
| Start Date | 2025-03-25 |
| Primary Completion | 2026-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 20 participants in total. It began in 2025-03-25 with a primary completion date of 2026-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study aims to integrate various data types, such as electronic health records, wearable device data, and environmental data, to create a comprehensive, personalized diabetes care model. The study will focus on people with type 2 diabetes living in specified vulnerable zip codes.
Eligibility Criteria
Inclusion Criteria * People with diabetes in the 18-65 years of age range * Diagnosed with type 2 diabetes * Resides in the specified high social vulnerability zip codes - 60619, 60620, 60621, 60636, 60644, 60624, 60609, 60612, 60617, 60623, 60628, 60629, 60639, 60645, 60649, 60651, 60652, 60653 * Speak and understand the English language * Willing to wear various devices (CGM and sports wristband) * Own a smartphone Exclusion Criteria * Subjects will be excluded from the study for the following reasons: * Any concern of not understanding informed consent * Unable to understand or unwilling to follow research protocol
Contact & Investigator
Andy Boyd, MD
PRINCIPAL INVESTIGATOR
University of Illinois at Chicago
Frequently Asked Questions
Who can join the NCT06989008 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Type 2 Diabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06989008 currently recruiting?
Yes, NCT06989008 is actively recruiting participants. Contact the research team at lquinn1@uic.edu for enrollment information.
Where is the NCT06989008 trial being conducted?
This trial is being conducted at Chicago, United States, Chicago, United States.
Who is sponsoring the NCT06989008 clinical trial?
NCT06989008 is sponsored by University of Illinois at Chicago. The principal investigator is Andy Boyd, MD at University of Illinois at Chicago. The trial plans to enroll 20 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.